Oncology & Cancer

Person-centered app helps women with breast cancer

The face-to-face meetings between the patient and the care provider might be successfully complemented with person-centered e-support. A preliminary evaluation of breast cancer patients shows that a newly developed app can ...

Oncology & Cancer

Interferon not beneficial for most stage III melanoma

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment ...

Oncology & Cancer

Impact of recurrence score assay varies with patient age

(HealthDay)—For women with early-stage breast cancer, the impact of receipt of the 21-gene recurrence score (RS) assay varies with patient age, according to a study published online Nov. 23 in the Journal of Clinical Oncology.

page 32 from 40